Early Pharmaceutical Sciences Involvement Facilitates Small Molecule Development: Importance of Salt and Polymorph Selection-Gail L. Strong-09/06/2011 - 8:30am

Event Information
Event Topic: 
Early Pharmaceutical Sciences Involvement Facilitates Small Molecule Development: Importance of Salt and Polymorph Selection
Event Date: 
09/06/2011 - 8:30am
Event Location: 
Sunnyvale City Council Chambers, 456 West Olive Ave., Sunnyale, CA
Speaker Information
Event Speaker: 
Gail L. Strong
Event Speaker Title: 
Senior Director
Event Speaker Company: 
Patheon Pharmaceutical Development Services
Event Speaker Bio: 

Gail L. Strong, Ph.D.

Gail L Strong, Ph.D., Senior Director, Pantheon Pharmaceutical Development Services, is an expert in pharmaceutical development with over 15 years experience bringing small molecules from discovery to late stage clinical trials. She has played a key role in the discovery team by providing physical chemical characterization, salt selection and hydrate and polymorph screening to the identification of lead compounds for development at the Upjohn Company.
Previously, Dr. Strong led the U.S. Pharmaceutics function for the Pharmacia Co. In that capacity the groups provided CMC transition for a molecule from discovery to early clinical trials. At Theravance Inc, Dr. Strong led the Oral Formulation development group which evaluated, developed and outsourced manufacture of oral drug products for clinical trials. She also led the GIPROK project with successfully moved TD-5018 through a Phase 2 proof of concept study and positioned it for Phase 3 evaluation.

Event Details
Cost: 
$0
Event Details: 

'